Literature DB >> 6826569

Biomaterials for drug delivery systems.

R G Buckles.   

Abstract

Drug delivery systems have unusual materials requirements which derive mainly from their therapeutic role: to administer drugs over prolonged periods of time at rates that are independent of patient-to-patient variables. The chemical nature of the surfaces of such devices may stimulate biorejection processes which can be enhanced or suppressed by the simultaneous presence of the drug that is being administered. Selection of materials for such systems is further complicated by the need for compatibility with the drug contained within the system. A review of selected drug delivery systems is presented. This leads to a definition of the technologies required to develop successfully such systems as well as to categorize the classes of drug delivery systems available to the therapist. A summary of the applications of drug delivery systems will also be presented. There are five major challenges to the biomaterials scientist: (1) how to minimize the influence on delivery rate of the transient biological response that accompanies implantation of any object; (2) how to select a composition, size, shape, and flexibility that optimizes biocompatibility; (3) how to make an intravascular delivery system that will retain long-term functionality; (4) how to make a percutaneous lead for those delivery systems that cannot be implanted but which must retain functionality for extended periods; and (5) how to make biosensors of adequate compatibility and stability to use with the ultimate drug delivery system-a system that operates with feedback control.

Entities:  

Keywords:  Biodegradable Delivery Systems; Contraception; Contraceptive Methods; Drugs--administraction and dosage; Economic Factors; Examinations And Diagnoses; Family Planning; Industry; Iud; Iud, Hormone Releasing; Literature Review; Macroeconomic Factors; Progesterone; Reproductive Control Agents; Research And Development; Size; Technology; Treatment

Mesh:

Substances:

Year:  1983        PMID: 6826569     DOI: 10.1002/jbm.820170110

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.

Authors:  S Mishra; D Bedja; C Amuzie; C A Foss; M G Pomper; R Bhattacharya; K J Yarema; S Chatterjee
Journal:  Biomaterials       Date:  2015-06-03       Impact factor: 12.479

2.  The effect of plasticizers on compatibility, mechanical properties, and adhesion strength of drug-free Eudragit E films.

Authors:  S Y Lin; C J Lee; Y Y Lin
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

3.  Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.

Authors:  Patrick J Marsac; Tonglei Li; Lynne S Taylor
Journal:  Pharm Res       Date:  2008-09-09       Impact factor: 4.200

4.  Chemical nature and structure of organic coating of quantum dots is crucial for their application in imaging diagnostics.

Authors:  Rumiana Bakalova; Zhivko Zhelev; Daisuke Kokuryo; Lubomir Spasov; Ichio Aoki; Tsuneo Saga
Journal:  Int J Nanomedicine       Date:  2011-08-18

Review 5.  Calcium Phosphate-Based Bioceramics in the Treatment of Osteosarcoma: Drug Delivery Composites and Magnetic Hyperthermia Agents.

Authors:  Tiê Menezes Oliveira; Fernanda Costa Brandão Berti; Sidney Carlos Gasoto; Bertoldo Schneider; Marco Augusto Stimamiglio; Lucas Freitas Berti
Journal:  Front Med Technol       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.